|
PRPF3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.28779999994688E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.640700E-04 |
| Normal-vs-Stage2 |
6.310300E-02 |
| Normal-vs-Stage3 |
3.387000E-01 |
| Normal-vs-Stage4 |
3.855000E-01 |
| Stage1-vs-Stage2 |
5.021400E-01 |
| Stage1-vs-Stage3 |
1.402230E-01 |
| Stage1-vs-Stage4 |
7.635600E-01 |
| Stage2-vs-Stage3 |
1.744830E-01 |
| Stage2-vs-Stage4 |
5.506600E-01 |
| Stage3-vs-Stage4 |
5.811600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.86129999996321E-06 |
| Normal-vs-AfricanAmerican |
9.296600E-03 |
| Normal-vs-Asian |
1.963990E-01 |
| Caucasian-vs-AfricanAmerican |
5.220800E-01 |
| Caucasian-vs-Asian |
5.486200E-01 |
| AfricanAmerican-vs-Asian |
7.378000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.57890000000083E-05 |
| Normal-vs-Female |
3.761600E-04 |
| Male-vs-Female |
5.023000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.384700E-03 |
| Normal-vs-Extreme_Weight |
1.118160E-03 |
| Normal-vs-Obese |
1.123900E-03 |
| Normal-vs-Extreme_Obese |
2.226400E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.565800E-01 |
| Normal_Weight-vs-Obese |
8.593400E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.081800E-01 |
| Extreme_Weight-vs-Obese |
6.845800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.731600E-01 |
| Obese-vs-Extreme_Obese |
6.390800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.943890E-02 |
| Normal-vs-Age(41-60Yrs) |
1.46710000004102E-06 |
| Normal-vs-Age(61-80Yrs) |
8.409300E-04 |
| Normal-vs-Age(81-100Yrs) |
6.561400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.933800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.978200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.360600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.015610E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.051390E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.449800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.26919999457564E-08 |
| Normal-VS-Type2 PRCC |
7.283000E-01 |
| Normal-VS-KIRP CIMP |
8.240400E-01 |
| Normal-VS-Unclassified PRCC |
1.549820E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.89999999999912E-06 |
| Type1 PRCC-VS-KIRP CIMP |
5.230200E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
3.343800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.391600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.970400E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
2.458000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.705600E-02 |
| Normal-vs-N1 |
6.997500E-02 |
| Normal-vs-N2 |
9.501200E-01 |
| N0-vs-N1 |
4.638600E-01 |
| N0-vs-N2 |
4.582400E-01 |
| N1-vs-N2 |
4.516800E-01 |
|
|
